Do Fair Comparisons or Harms Data Increase Responsiveness to Feedback About Antibiotic Prescribing: 2x2 Factorial Trial
NCT04594200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5107
Last updated 2023-01-05
Summary
Antibiotic overuse is common and antibiotic prescribing contributes to rising rates of antimicrobial resistance. Primary care physicians prescribe the majority of all antibiotics and there is large inter-physician variability in prescribing that cannot be explained by differences in patient populations.
Peer comparison audit and feedback (A\&F) can act as an effective behavioural intervention to reduce unnecessary antibiotic use. The range of effects seen in prior A\&F trials could be attributed, at least in part, to differences in the way the feedback interventions were designed. In fall 2018, the investigators conducted an audit and feedback trial of mailed letters to 3500 family physicians in Ontario who prescribe the highest volume of antibiotics \[NCT03776383\]. While effective, family physicians questioned the credibility of the report in terms of its ability to fairly account for their practice size and population.
In Ontario, A\&F is routinely offered to primary care providers from a variety of sources. Ontario Health - an agency created by the Government of Ontario - provides A\&F via email to physicians who voluntarily sign up for their "MyPractice" reports. These are multi-topic reports with aggregated (physician-level) data. As of November 2021, the MyPractice reports for family physicians will include data on antibiotic prescribing. To date, less than half of Ontario family physicians have signed up for the MyPractice reports from Ontario Health.
For this study, the investigators will conduct a trial to investigate the effect of A\&F in family physicians not already receiving A\&F through a MyPractice: Primary Care report. Physicians who do not already receive antibiotic prescribing feedback through a MyPractice report will receive personalized antibiotic prescribing feedback through a letter mailed out from PHO. This large-scale evaluation provides an opportunity to evaluate not only whether A\&F using such data is helpful in the post-covid context, but how best to design the A\&F intervention and to explore why we observed (or not) changes in antibiotic prescribing.
Conditions
Interventions
- BEHAVIORAL
-
Audit and Feedback (A&F)
In this protocol, we propose comparing 2 intervention design elements in a multifactorial design. Specifically, we will evaluate: i) an emphasis on antibiotic-associated harms in comparison to messages that focus on lack of benefit; ii) simple versus adjusted peer comparators to represent a target for the prescribing quality indicators We will also investigate the effects of the inclusion of materials developed by Choosing Wisely Canada (CWC) - namely the viral prescription pad - to help physicians act upon the feedback to reduce their prescribing
Sponsors & Collaborators
-
Ontario Agency for Health Protection and Promotion
collaborator OTHER_GOV -
College of Family Physicians of Canada
collaborator OTHER -
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
Women's College Hospital
lead OTHER
Principal Investigators
-
Noah M Ivers · WCH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-15
- Primary Completion
- 2022-07-15
- Completion
- 2023-01-01
Countries
- Canada
Study Locations
More Related Trials
-
N-of-1 Trials of Interventions to Improve Decision-making for Antibiotic Use
NCT05451836 ·Status: COMPLETED ·Phase: NA
-
Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled Trial
NCT00250900 ·Status: COMPLETED ·Phase: NA
-
Israeli Judicious Antibiotic Prescription Study
NCT01187758 ·Status: COMPLETED ·Phase: NA
-
Outcome of Patients After a Negative Oral Challenge to Amoxicillin
NCT04922034 ·Status: COMPLETED
-
Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review Study
NCT06959667 ·Status: ACTIVE_NOT_RECRUITING
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
NCT03487562 ·Status: COMPLETED ·Phase: PHASE1
-
Telephone-Based Re-education for Hp Eradication
NCT03193450 ·Status: COMPLETED ·Phase: NA
-
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
NCT07217002 ·Status: ACTIVE_NOT_RECRUITING
-
Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.
NCT04698057 ·Status: WITHDRAWN ·Phase: PHASE3
-
Amoxicillin Challenge for Penicillin Allergy Diagnosis
NCT03757052 ·Status: UNKNOWN ·Phase: NA
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)
NCT00722735 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects
NCT01026545 ·Status: COMPLETED ·Phase: PHASE1
-
Helicobacter Pylori Resistance
NCT05019586 ·Status: COMPLETED
-
An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia
NCT00648726 ·Status: COMPLETED ·Phase: PHASE3
-
Antimicrobial Stewardship in Community Pharmacy
NCT04219553 ·Status: COMPLETED ·Phase: NA
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by Bacteria
NCT00269932 ·Status: COMPLETED ·Phase: PHASE3
-
Digital Otoscope Versus Education and Feedback for Otitis Media in Young Children
NCT06731660 ·Status: COMPLETED ·Phase: NA
-
Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection
NCT01930955 ·Status: WITHDRAWN ·Phase: NA
-
Comparative Efficacy of Single-dose Doxycycline Versus Standard 5- Day Amoxicillin Treatment
NCT03765931 ·Status: COMPLETED ·Phase: PHASE4
-
Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora
NCT00354952 ·Status: COMPLETED ·Phase: NA
-
Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy
NCT06396780 ·Status: ACTIVE_NOT_RECRUITING
-
Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia
NCT01032694 ·Status: TERMINATED
-
An Open Label Trial of Azithromycin in Chronic Productive Cough
NCT02196493 ·Status: UNKNOWN ·Phase: PHASE3